✨
AI Summary
- Emily Conley discusses small molecules for a rare kidney disease.
- Renasant Bio targets autosomal dominant polycystic kidney disease (ADPKD).
- Developing corrective and potentiating therapies for genetic disorders.
Guests on This Episode
EC
Emily Conley
1 podcast appearance